Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Hyperglycemia
  • Insulin Sensitivity
Type
Interventional
Phase
Not Applicable
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: placebo-controlled, randomized clinical trialMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Masking Description: Participants, investigators and care providers at the scene are all blinded to the allocation of treatment group. Data collected will be analyzed by another investigator who is blinded to the study design.Primary Purpose: Prevention

Participation Requirements

Age
Between 30 years and 65 years
Gender
Both males and females

Description

Highland barley ?-glucan belongs to the group of prebiotics and has been found to be associated with multiple health benefits. However, its protective role in subjects with hyperglycemia are remain unclear. This study aims to examine the effect of 8-week prebiotics supplementation on glucose managem...

Highland barley ?-glucan belongs to the group of prebiotics and has been found to be associated with multiple health benefits. However, its protective role in subjects with hyperglycemia are remain unclear. This study aims to examine the effect of 8-week prebiotics supplementation on glucose management in subjects with hyperglycemia. By understanding the mechanism by which prebiotics exert the beneficial effects, we can better control the rising prevalence of hyperglycemia, which is a major risk factor for cardiovascular diseases.

Tracking Information

NCT #
NCT04636489
Collaborators
Not Provided
Investigators
Principal Investigator: Min Xia, PhD Sun Yat-sen University